Aldeyra Therapeutics, Inc.

Historical 13F Holders

Symbol
ALDX
CUSIP
01438T106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 01438T106 since 12/18/2024, largest first.

Filer % of Class Filed
AQR Capital Management, LLC 13G
6.2% 8/12/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
BlackRock, Inc. 13G/A 1.7% 7/27/2026
Event 6/30/2026
Perceptive Advisors LLC 13G/A
0% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 9 286 k $346 k
2026 Q2 115 36.7 M $78.2 M
2026 Q1 136 37.3 M $63.3 M
2025 Q4 145 39.0 M $202 M
2025 Q3 139 39.2 M $204 M
2025 Q2 130 34.7 M $133 M
2025 Q1 138 37.9 M $226 M
2024 Q4 129 37.3 M $186 M
2024 Q3 119 36.7 M $250 M
2024 Q2 110 35.7 M $118 M
2024 Q1 110 36.1 M $118 M
2023 Q4 113 35.7 M $126 M
2023 Q3 128 37.8 M $252 M
2023 Q2 133 39.0 M $328 M
2023 Q1 120 35.6 M $353 M
2022 Q4 105 34.4 M $239 M
2022 Q3 101 39.4 M $210 M
2022 Q2 105 37.0 M $147 M
2022 Q1 126 38.7 M $172 M
2021 Q4 144 46.6 M $187 M
2021 Q3 137 39.7 M $349 M
2021 Q2 148 55.2 M $628 M
2021 Q1 119 40.4 M $480 M
2020 Q4 109 22.7 M $157 M
2020 Q3 92 23.8 M $176 M
2020 Q2 91 14.8 M $61.7 M
2020 Q1 76 16.8 M $41.4 M
2019 Q4 81 18.0 M $105 M
2019 Q3 76 16.9 M $89.0 M
2019 Q2 86 17.0 M $102 M
2019 Q1 90 16.4 M $148 M
2018 Q4 81 17.4 M $144 M
2018 Q3 104 18.2 M $251 M
2018 Q2 68 12.2 M $96.6 M
2018 Q1 46 10.3 M $77.1 M
2017 Q4 38 9.78 M $66.5 M
2017 Q3 36 9.22 M $66.4 M
2017 Q2 27 7.45 M $34.8 M
2017 Q1 26 8.81 M $42.5 M
2016 Q4 21 6.14 M $32.8 M
2016 Q3 22 6.11 M $47.9 M
2016 Q2 25 6.36 M $36.2 M
2016 Q1 28 4.37 M $18.3 M
2015 Q4 21 4.43 M $30.0 M
2015 Q3 23 5.29 M $30.8 M
2015 Q2 24 4.23 M $32.9 M
2015 Q1 15 1.69 M $17.4 M
2014 Q4 5 870 k $6.28 M
2014 Q3 7 859 k $5.16 M
2014 Q2 7 852 k $5.64 M